A Phase III clinical trial in chronic obstructive pulmonary disease (COPD).
Latest Information Update: 08 Jan 2025
Price :
$35 *
At a glance
- Drugs MG-K10 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 08 Jan 2025 New trial record